I am a life science entrepreneur with over nine years of experience in founding and leading innovative companies that leverage cutting-edge technologies to address unmet needs in cancer research and diagnostics. As the co-founder and CEO of bioSyntagma, I developed and commercialized a spatial 'omics platform and informatics tools that enable high-resolution mapping of tumors. I have also had the privilege of scaling lab operations for several clinical diagnostic companies, including Renaissance Diagnostics which was acquired in 2022. Currently, I serve as the principal of Copper State Lab Services, which operates the clinical arm of a venture-backed precision diagnostics company. My mission is to make a meaningful impact in the lives of people all over the world by improving patient outcomes and supporting the development of precision healthcare.